Financial Assets and Liabilities (Tables)

12 Months Ended

Oct. 31, 2018

Financial Assets And Liabilities [Abstract]

Summary of Available-for-Sale Securities

As of October 31, 2018, the balances of the Company's cash equivalents and non-marketable equity securities investments were:

	Cost		Gross Unrealized Gains		Gross Unrealized Losses Less Than 12 Continuous Months		Gross Unrealized Losses 12 Continuous Months or Longer		Estimated Fair Value(1)
	(in thousands)
Cash equivalents:
Money market funds	$	165,296	$	—	$	—	$	—	$	165,296
Total:	$	165,296	$	—	$	—	$	—	$	165,296
Other long-term assets:
Non-marketable equity securities	$	10,892	$	—	$	—	$	—	$	10,892
Total:	$	10,892	$	—	$	—	$	—	$	10,892

(1) See Note 6.Fair Value Measures for further discussion on fair values of cash equivalents.

As of October 31, 2017, the balances of our cash equivalents and non-marketable equity securities investments were:

	Cost		Gross Unrealized Gains		Gross Unrealized Losses Less Than 12 Continuous Months		Gross Unrealized Losses 12 Continuous Months or Longer		Estimated Fair Value(1)
	(in thousands)
Cash equivalents:
Money market funds	$	560,594	$	—	$	—	$	—	$	560,594
Total:	$	560,594	$	—	$	—	$	—	$	560,594
Other long-term assets:
Non-marketable equity securities	$	7,826	$	—	$	—	$	—	$	7,826
Total:	$	7,826	$	—	$	—	$	—	$	7,826

(1) See Note 6. Fair Value Measures for further discussion on fair values of cash equivalents.

Effects on Changes in Fair Values of Non-Designated Forward Contracts

The effects of the changes in the fair values of non-designated forward contracts for fiscal years 2018, 2017, and 2016 are summarized as follows:

	October 31,
	2018		2017		2016
	(in thousands)
Gain (loss) recorded in other income (expense), net	$	3,361	$	1,359	$	(4,533	)

Notional Amounts of Derivative Instruments

The notional amounts in the table below for derivative instruments provide one measure of the transaction volume outstanding:

	As of October 31, 2018			As of October 31, 2017
	(in thousands)
Total gross notional amount	$	1,135,549		$	955,139
Net fair value	$	(18,120	)	$	14,052

Fair Values of Derivative Instrument Designated and Non-Designated as Hedging Instruments in Balance Sheet

The following represents the balance sheet location and amount of derivative instrument fair values segregated between designated and non-designated hedge instruments:

	Fair Values of derivative instruments designated as hedging instruments		Fair Values of derivative instruments not designated as hedging instruments
	(in thousands)
As of October 31, 2018
Other current assets	$	4,771	$	131
Accrued liabilities	$	22,890	$	132
As of October 31, 2017
Other current assets	$	16,582	$	15
Accrued liabilities	$	2,485	$	59

Income Statement Location and Amount of Gains and Losses on Derivative Instrument Fair Values for Designated Hedge Instruments, Net of Tax

The following table represents the income statement location and amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax:

	Location of gain (loss) recognized in OCI on derivatives	Amount of gain (loss) recognized in  OCI on derivatives (effective portion)			Location of gain (loss) reclassified  from OCI	Amount of gain (loss) reclassified  from OCI (effective  portion)
	(in thousands)
Fiscal year ended October 31, 2018
Foreign exchange contracts	Revenue	$	693		Revenue	$	1,103
Foreign exchange contracts	Operating expenses	(18,121		)	Operating expenses	9,785
Total		$	(17,428	)		$	10,888
Fiscal year ended October 31, 2017
Foreign exchange contracts	Revenue	$	7,582		Revenue	$	(2,759	)
Foreign exchange contracts	Operating expenses	13,346			Operating expenses	(805		)
Total		$	20,928			$	(3,564	)
Fiscal year ended October 31, 2016
Foreign exchange contracts	Revenue	$	(14,580	)	Revenue	$	(8,585	)
Foreign exchange contracts	Operating expenses	(11,259		)	Operating expenses	(12,125		)
Total		$	(25,839	)		$	(20,710	)

Ineffective Portion and Portion Excluded from Effectiveness Testing of Derivative Hedge Gains (Losses)

The following table represents the ineffective portions and portions excluded from effectiveness testing of the hedge gains (losses) for derivative instruments designated as hedging instruments, which are recorded in other income (expense) income, net:

Foreign exchange contracts	Amount of gain (loss) recognized in income statement on derivatives (ineffective portion)(1)		Amount of gain (loss) recognized in income statement on derivatives (excluded from effectiveness testing)(2)
	(in thousands)
Fiscal year ended October 31, 2018	$	467	$	2,848
Fiscal year ended October 31, 2017	$	311	$	3,018
Fiscal year ended October 31, 2016	$	1,468	$	6,058

(1) The ineffective portion includes forecast inaccuracies.

(2) The portion excluded from effectiveness testing includes the discount earned or premium paid for the contracts.

Schedule of Maturities of Long-term Debt

Outstanding principal payments under the Term Loan are due as follows:

Fiscal year	(in thousands)
2019	$	14,062
2020	17,813
2021	27,187
2022	75,000
Total	$	134,062